The effect of omega3 fatty acid capsules on primi gravida during pregnancy depression

The effect of omega3 fatty acid capsules on primi gravida during pregnancy depression that refer to health clinic in shiraz, Iran

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2012121011717N1

Enrollment

Registered

2013-01-08

Start date

2012-07-07

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression. episode-depressive-mild

Interventions

Intervention 1: Intervention withomega 3capsules for each patient 1000 mg/day in 6weeks. Intervention 2: placebo capsules are used 1 per day for 6 weeks.

Treatment - Drugs

Intervention withomega 3capsules for each patient 1000 mg/day in 6weeks.

placebo capsules are used 1 per day for 6 weeks

Eligibility

Sex/Gender

Female

Age

18 Years to 44 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: willingness to participate; primi gravidia woman from 18 years old; not having disease such as heart disease, hyperthyroidism, hypothyroidism, renal infection and diabetes mellitus; not taking any medication that effect depression such as anti depressent, SRII; no familial disorder; no psychotic problem and no psychotic consultation. Exclusion criteria: unwillingness to cooperate after the beginning of the study and showing allergic reaction to omega3.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Depression. Timepoint: At the start of intervention- After intervention. Method of measurement: Beck depression inventory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactkavianimasumeh

Fatemeh (PBUH) College of Nursing and Midwifery Shira

kavianm@sums.ac.ir+98 71 1647 4252

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026